You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. NOVEL MINIMALLY INVASIVE METHOD TO IDENTIFY LUNG MALIGNANCIES BY MRI

    SBC: 3TP IMAGING SCIENCES            Topic: N/A

    DESCRIPTION (provided by applicant): Project Summary. The overall goal of this research program is to develop a novel magnetic resonance (MR) image analysis method that can distinguish between malignant and benign lung nodules in patients who are undergoing diagnostic evaluation for lung cancer. 3TP Imaging Sciences has developed MR image analysis software that can be used to characterize the stat ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  2. Auto-antibody profiling of non-small cell lung cancer

    SBC: 20 20 Genesystems Inc            Topic: N/A

    DESCRIPTION (provided by applicant): Tumor markers, measured in peripheral blood, could assist in diagnosis and management of non-small cell lung cancer (NSCLC) and potentially improve historically dismal outcomes. Circulating antibodies, generated to a wide range of tumor-associated proteins, can be translated into a valuable blood test for lung cancer. Preliminary data supports this hypothesis. ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  3. Novel Strategy for BIV Vector Site-Specific Integration

    SBC: ADVANCED VISION THERAPIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Lentivirus-based gene transfer systems represent a promising gene delivery technology, as they integrate into the genome of the target cell and mediate sustained expression of the transferred gene. To date, the majority of studies have used vectors based on the Human Immunodeficiency Virus (HIV), a human pathogen and the causative agent of AIDS. Advanced Vision ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  4. A Novel BIV vector pseudotyped with thogoto virus gp75

    SBC: ADVANCED VISION THERAPIES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Lentivirus-based gene transfer systems represent a promising gene delivery technology, as they integrate into the genome of the target cell and mediate sustained expression of the transferred gene. Advanced Vision Therapies, Inc. (AVT) has developed a proprietary lentiviral vector system based on the bovine immunodeficiency virus (BIV), an animal lentivirus not ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  5. Nisin as a decontaminant for B. anthracis spores on human skin

    SBC: AFG BIOSOLUTIONS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Project summary: An attack or terrorist event using spores of Bacillus anthracis continues to be an imminent threat. In the event of such an attack, many surfaces including human skin will become contaminated with disseminated spores. Spores carried on human skin not only pose the threat of developing into cutaneous anthrax, but can also be carried to other loc ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  6. Microfluidic Controlled Gel-Drop Microarrays for Biothreat Diagnostic Devices

    SBC: AKONNI BIOSYSTEMS INC            Topic: N/A

    DESCRIPTION (provided by applicant): Whether in clinical or epidemiological settings, there is a continued need in identification of B. anthracis and unambiguous discrimination it from close relatives and organisms with similar characteristics. Genomic analysis provides direct information about tested organism in opposite to indirect, phenotype analysis, however represents in current certified Ant ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  7. Oral Formulation of Zonulin Antagonist AT-1001 for Diabe

    SBC: ALBA THERAPEUTICS CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): The trigger for autoimmune destruction of pancreatic beta cells in Type 1 diabetes (T1D) is unclear. Evidence exists for the role of increased intestinal permeability, secondary to intestinal tight junctions (tj) disassembly, in the pathogenesis of various autoimmune diseases including T1 D. Over the last decade our studies have focused on the mechanism(s) of a ...

    STTR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  8. Novel Small Molecule Therapeutic for Spinal Cord Injury

    SBC: Angion Biomedica Corp.            Topic: N/A

    DESCRIPTION (provided by applicant): It is estimated that the annual incidence of spinal cord injury (SCI), not including those who die at the scene of the accident, is approximately 11,000 cases each year. The number of living patients in the United States as of December 2003 who have SCI, has been estimated as being approximately 243,000 persons. After initial injury, about half of those affect ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  9. Modified Diphtheria Toxin IL-7 Fusion Toxins

    SBC: ANJIN GROUP, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Sweeney et al. (1998) originally reported the construction of DAB389IL-7, a fusion protein based on diphtheria toxin (DT), and proposed that this fusion protein could be employed as a therapeutic agent for hematological malignancies, including acute lymphoblastic leukemia, chronic lymphocytic leukemia, acute myelogenous leukemia and Sezary syndrome. Studies by ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health
  10. Education Data Management System

    SBC: Ansya Enterprise Solutions            Topic: N/A

    As the global economic competition for qualified workforce increases, our country’s ability to compete effectively in the global marketplace depends on our school systems’ ability to create a competitive workforce. Recently, there has been an increase in expectation on American schools to perform better than ever before in preparing students to meet rigorous educational standards. Keeping in l ...

    SBIR Phase I 2006 Department of Education
US Flag An Official Website of the United States Government